Production of Soluble and Functional Anti-TNF-α Fab' Fragment in Cytoplasm of E. coli: Investigating the Effect of Process Conditions on Cellular Biomass and Protein Yield Using Response Surface Methodology-Reference-Cited by-同舟云学术

Production of Soluble and Functional Anti-TNF-α Fab' Fragment in Cytoplasm of E. coli: Investigating the Effect of Process Conditions on Cellular Biomass and Protein Yield Using Response Surface Methodology

Published:2021-05-23 Issue:5 Volume:40 Page:786-798
ISSN:1572-3887
Container-title:The Protein Journal
language:en
Short-container-title:Protein J

Author:

Talaei Andisheh,Mazaheri Somayeh,Bayat Elham,Bakhshandeh Behnaz,Sabzalinejad Masoumeh,Damough Shadi,Mahboudi Fereidoun,Nematollahi Leila^ORCID,Talebkhan Yeganeh

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Biochemistry,Bioengineering,Analytical Chemistry,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s10930-021-09996-3.pdf

Reference25 articles.

1. Hua Q et al (2004) Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures. Appl Environ Microbiol 70(4):2354–2366

2. Graumann K, Premstaller A (2006) Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnol J Healthcare Nutr Technol 1(2):164–186

3. Georgiou G, Valax P (1996) Expression of correctly folded proteins in Escherichia coli. Curr Opin Biotechnol 7(2):190–197

4. Graham L, Beveridge T, Nanninga N (1991) Periplasmic space and the concept of the periplasm. Trends Biochem Sci 16(9):328–329

5. Stock JB, Rauch B, Roseman S (1977) Periplasmic space in Salmonella typhimurium and Escherichia coli. J Biol Chem 252(21):7850–7861

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production of bioactive recombinant monoclonal antibody fragment in periplasm of Escherichia coli expression system;Preparative Biochemistry & Biotechnology;2023-04-11

2. Optimization of the in-vitro refolding of biotherapeutic Fab Ranibizumab;Biochemical Engineering Journal;2022-11